Type of lung cancer-Non-small cell lung carcinoma (NSCLC)-Adenocarcinoma Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC)-Adenocarcinoma Posts on Medivizor

Evaluating patient-reported outcomes in the treatment of metastatic non-small-cell lung cancer with pembrolizumab plus pemetrexed–platinum

Evaluating patient-reported outcomes in the treatment of metastatic non-small-cell lung cancer with pembrolizumab plus pemetrexed–platinum

Posted by on Aug 15, 2020 in Lung cancer | 0 comments

In a nutshell The study evaluated treatment outcomes reported by patients with metastatic non-small-cell lung cancer (mNSCLC) who were treated by pembrolizumab (Keytruda) and pemetrexed (Alimta) and platinum chemotherapy. The authors found that adding pembrolizumab to pemetrexed-platinum chemotherapy improved health-related quality of life (HRQOL)...

Read More

Is bevacizumab a safe and effective treatment for advanced non-small cell lung cancer?

Is bevacizumab a safe and effective treatment for advanced non-small cell lung cancer?

Posted by on Apr 12, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of bevacizumab (Avastin) in combination with platinum-based chemotherapy in Hungarian patients with non-small-cell lung cancer (NSCLC). They found that this treatment combination was associated with improved patient survival. Some background The most common type of lung cancer is...

Read More

Is the biosimilar drug ABP 125 as effective as bevacizumab in patients with lung cancer?

Is the biosimilar drug ABP 125 as effective as bevacizumab in patients with lung cancer?

Posted by on Jan 17, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how safe and effective is biosimilar ABP 215 in non-small cell lung cancer (NSCLC), compared to bevacizumab (Avastin). This study concluded that this drug is as safe and effective as bevacizumab in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung...

Read More

Testing biological therapy in treating KRAS-mutant NSCLC

Posted by on Apr 16, 2016 in Lung cancer | 0 comments

In a nutshell This study aimed to assess the efficacy and safety of anti-cancer drug trametinib (Mekinist) in comparison to docetaxel (Taxotere) in treating patients with KRAS-mutation-positive advanced non-small-cell lung cancer (NSCLC). The study concluded that there was no difference in efficacy between trametinib and docetaxel however trametinib...

Read More

Treatments for when lung cancer progresses

Treatments for when lung cancer progresses

Posted by on Nov 9, 2015 in Lung cancer | 0 comments

In a nutshell This review discussed the use of nintedanib (Vargatef) in non-small cell lung cancer that has progressed despite treatment. Some background Non-small cell lung cancer (NSCLC) is often not diagnosed until the disease is advanced (spread to the lymph nodes or other areas of the body). Chemotherapy is the first-line treatment, but the...

Read More

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Posted by on May 19, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to evaluate the effect of erlotinib (Tarceva) in combination with pemetrexed (Alimta) and cisplatin (Platinol) in lung cancer that had spread into the brain (brain metastases). Some background Lung adenocarcinoma is the cancer of glandular cells of lungs. It is a common type of non-small cell lung...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor